Bioequivalence Study to Compare Bosentan 32 mg Dispersible Tablets Versus Tracleer® 32 mg Tablets

NCT06484673 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Bosentan Dispersible Tablets
DRUG: Tracleer Tablet for Oral Suspension

Sponsor

Humanis Saglık Anonim Sirketi